XML 20 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated statement of comprehensive income - CAD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2025
Jan. 31, 2025
Apr. 30, 2024
Apr. 30, 2025
Apr. 30, 2024
Statement of comprehensive income [abstract]          
Net income $ 2,007 $ 2,171 $ 1,749 $ 4,178 $ 3,477
Net foreign currency translation adjustments          
Net gains (losses) on investments in foreign operations (3,061) 2,453 1,244 (608) (359)
Net gains (losses) on hedges of investments in foreign operations 1,897 (1,571) (779) 326 183
Other comprehensive income, net of tax, exchange differences on translation (1,164) 882 465 (282) (176)
Net change in debt securities measured at FVOCI          
Net gains (losses) on debt securities measured at FVOCI (17) 110 21 93 181
Net (gains) losses reclassified to net income (6) (9) (21) (15) (31)
Other comprehensive income, net of tax, debt securities (23) 101   78 150
Net change in cash flow hedges          
Net gains (losses) on derivatives designated as cash flow hedges 472 326 (374) 798 497
Net (gains) losses reclassified to net income (194) (35) (92) (229) (208)
Other comprehensive income, net of tax, cash flow hedges 278 291 (466) 569 289
OCI, net of income tax, that is not subject to subsequent reclassification to net income          
Net gains (losses) on post-employment defined benefit plans (47) 19 13 (28) (65)
Net gains (losses) due to fair value change of fair value option (FVO) liabilities attributable to changes in credit risk 157 (2) (57) 155 (256)
Net gains (losses) on equity securities designated at FVOCI 12 3 (10) 15 (10)
OCI, net of income tax, that will not be reclassified to profit or loss, net of tax 122 20 (54) 142 (331)
Total OCI [1] (787) 1,294 (55) 507 (68)
Comprehensive income 1,220 3,465 1,694 4,685 3,409
Comprehensive income attributable to non-controlling interests 9 8 10 17 22
Preferred shareholders and other equity instrument holders 78 88 61 166 128
Common shareholders 1,133 3,369 1,623 4,502 3,259
Comprehensive income attributable to equity shareholders 1,211 3,457 1,684 4,668 3,387
Net foreign currency translation adjustments          
Income tax (expense) benefit, Net gains (losses) on investments in foreign operations 79 (63) (34) 16 11
Income tax (expense) benefit, Net gains (losses) on hedges of investments in foreign operations (216) 152 78 (64) (18)
Income tax (expense) benefit relating to exchange differences on translation of other comprehensive income (137) 89 44 (48) (7)
Net change in debt securities measured at FVOCI          
Income tax (expense) benefit, Net gains (losses) on debt securities measured at FVOCI 17 (11) (2) 6 (34)
Income tax (expense) benefit, Net (gains) losses reclassified to net income 2 3 8 5 12
Income tax (expense) benefit relating to debt securities of other comprehensive income 19 (8) 6 11 (22)
Net change in cash flow hedges          
Income tax (expense) benefit, Net gains (losses) on derivatives designated as cash flow hedges (181) (126) 144 (307) (191)
Income tax (expense) benefit, Net (gains) losses reclassified to net income 74 14 35 88 80
Income tax (expense) benefit relating to cash flow hedges of other comprehensive income (107) (112) 179 (219) (111)
Not subject to subsequent reclassification to net income          
Income tax (expense) benefit, Net gains (losses) on post-employment defined benefit plans 19 (8) (5) 11 26
Income tax (expense) benefit, Net gains (losses) due to fair value change of FVO liabilities attributable to changes in credit risk (60)   21 (60) 98
Income tax (expense) benefit, Net gains (losses) on equity securities designated at FVOCI (5) (1) 3 (6) 3
Income tax (expense) benefit, Net gains (losses) not subject to subsequent reclassification to net income (46) (9) 19 (55) 127
Income tax (expense) benefit relating to components of other comprehensive income $ (271) $ (40) $ 248 $ (311) $ (13)
[1] Includes $20 million of gains for the quarter ended April 30, 2025 (January 31, 2025: $3 million of losses; April 30, 2024: $1 million of gains), and $17 million of gains for the six months ended April 30, 2025 (April 30, 2024: $54 million of gains), relating to our investments in equity-accounted associates and joint ventures.